Yongzhe Piao

Kobe, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Real-World Evidence of FOLFIRI Combined with Anti-Angiogenesis Inhibitors or Anti-EGFR Antibodies for Patients with Early Recurrence Colorectal Cancer After Adjuvant FOLFOX/CAPOX Therapy: A Japanese Claims Database Study.

Real-World Evidence of FOLFIRI Combined with Anti-Angiogenesis Inhibitors or Anti-EGFR Antibodies for Patients with Early Recurrence Colorectal Cancer After Adjuvant FOLFOX/CAPOX Therapy: A Japanese Claims Database Study.

Journal: Targeted oncology

Published: April 05, 2024

Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study.

Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study.

Journal: Journal of gastric cancer

Published: June 27, 2022

The clinical position of ramucirumab-containing regimens for advanced gastric cancer: a review of clinical trial data.

The clinical position of ramucirumab-containing regimens for advanced gastric cancer: a review of clinical trial data.

Journal: Future oncology (London, England)

Published: June 15, 2022

Treatment Pattern for Advanced Gastric Cancer in Japan and Factors Associated with Sequential Treatment: A Retrospective Administrative Claims Database Study.

Treatment Pattern for Advanced Gastric Cancer in Japan and Factors Associated with Sequential Treatment: A Retrospective Administrative Claims Database Study.

Journal: Advances in therapy

Published: July 28, 2021

Role of nutritional care and general guidance for patients with advanced or metastatic gastric cancer.

Role of nutritional care and general guidance for patients with advanced or metastatic gastric cancer.

Journal: Future oncology (London, England)

Published: May 28, 2021

Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study.

Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study.

Journal: Cancer medicine

Published: April 28, 2021

A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan.

A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: November 24, 2020

Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial.

Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial.

Journal: Clinical drug investigation

Published: October 08, 2020

Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors.

Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 21, 2020

Evaluating clinical impact of a shortened infusion duration for ramucirumab: a model-based approach.

Evaluating clinical impact of a shortened infusion duration for ramucirumab: a model-based approach.

Journal: Cancer chemotherapy and pharmacology

Published: September 16, 2020

Treatment sequences of patients with advanced colorectal cancer and use of second-line FOLFIRI with antiangiogenic drugs in Japan: A retrospective observational study using an administrative database.

Treatment sequences of patients with advanced colorectal cancer and use of second-line FOLFIRI with antiangiogenic drugs in Japan: A retrospective observational study using an administrative database.

Journal: PloS one

Published: July 21, 2020

Incidence of Proteinuria among Japanese Colorectal Cancer Patients after Receiving Ramucirumab-Cohort Study Using Claim Database

Incidence of Proteinuria among Japanese Colorectal Cancer Patients after Receiving Ramucirumab-Cohort Study Using Claim Database

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: June 17, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026